Connect with us

Technology

CustomerInsights.AI (CIAI) and Ikigai Labs Announce Strategic Collaboration to Innovate AI Solutions for the Pharmaceutical Industry

Published

on

SCOTTSDALE, Ariz., July 19, 2024 /PRNewswire/ — CustomerInsights.AI (CIAI) is excited to announce a strategic collaboration with Ikigai Labs to explore the potential of pharma-specific enterprise grade GenAI for structured data sets. This collaboration aims to address critical use-cases in the pharmaceutical industry, including integrated sales forecasting, call routing, resource planning, pharmacy fraud detection, and automated data matching at scale.

The partnership will connect CIAI’s ciPARTHENON™ Commercial Analytics Cloud, which offers 40+ out-of-the-box apps, with IKIGAI’s state-of-the-art large graphical model (LGM) platform. The collaboration will advance highly scalable AI solutions to meet the unique challenges of the pharmaceutical sector.

Abhay Jajoo, CEO of CustomerInsights.AI, said, “Teaming up with Ikigai unlocks endless possibilities. Together, through purpose-built AI apps, we will support the Life Sciences data and analytics market, efficiently and effectively, driving innovation and meaningful change. Gen AI for structured data will be a game changer for Pharma due to the availability of large-scale syndicated datasets in this Industry that are waiting to be explored”

Kamal Ahluwalia, President of IKIGAI, added, “Partnering with CIAI will advance our mission to unlock the value of tabular and time series data for industry. Our AI securely learns, uncovers, and explains patterns across only our customer’s data, making it ideal for enterprise use cases. We’re already driving outcomes in demand forecasting, inventory optimization, and workforce planning. With CustomerInsights.AI we will unlock cost savings, efficiencies, and competitive advantage achieved by connecting the right data and actions at the right time, unlocking tremendous value for patients and healthcare providers.”

The collaboration between CustomerInsights.AI and Ikigai Labs reflects their commitment to leveraging the latest technology to develop innovative AI solutions for the pharmaceutical industry. The exploratory phase will engage pharmaceutical leaders in collaborative projects focused on operational excellence and impactful results.

About CIAI

CustomerInsights.AI was founded in 2018 with the vision of democratizing business insights to improve commercial performance and turn data into a competitive advantage for clients. Our commercial Analytics cloud, ciPARTHENON™, is a ready-to-deploy, no-code, unified data management and analytics platform built specifically for Life Sciences companies. For more information, visit https://www.CustomerInsights.AI.

About Ikigai

Ikigai generative AI transforms tabular and time series data, empowering businesses with predictive and actionable insights. Grounded in award-winning MIT research, Ikigai’s Large Graphical Model (LGM) platform powers its aiMatch, aiCast and aiPlan models and AI solutions for data reconciliation, forecasting and scenario planning. Seamlessly integrating with any IT setup, Ikigai supports over 200 data sources for ease of integration. With proven results like a 20% improvement in forecasting accuracy and 70% reduction in data analysis time, Ikigai is transforming industries with its unparalleled efficiency and precision. To learn more and try Ikigai, visit https://www.ikigailabs.io.

 

 

View original content:https://www.prnewswire.com/news-releases/customerinsightsai-ciai-and-ikigai-labs-announce-strategic-collaboration-to-innovate-ai-solutions-for-the-pharmaceutical-industry-302203042.html

SOURCE CustomerInsights.AI

Continue Reading

Technology

Datavault AI Founder Nathaniel Bradley Sues Board

Published

on

By

WILMINGTON, Del., Nov. 6, 2026 /PRNewswire/ — Lawsuit Alleges Chairman and CFO Brett Moyer Engineered a Weekend Lockout While Keeping a $90–$100 Million Financing Offer From Independent Directors

Datavault AI Founder Nathaniel Bradley Sues Board

Nathaniel Bradley, the founder whose technology became Nasdaq-listed Datavault AI Inc. (NASDAQ: DVLT), today filed a lawsuit in the Delaware Court of Chancery asking the court to declare his contested ouster as CEO void and restore him to office. The complaint alleges that Board Chairman and CFO Brett Moyer “suspended” Bradley without a Board vote, cut off his email, and then rushed through a defective Sunday meeting, all while a $90–$100 million financing lifeline sat on the table.

On October 30, two days after Bradley asked the Board to consider removing Moyer as CFO, Moyer “suspended” Bradley on his own perceived authority. According to the complaint, no Board meeting was held and no written consent was circulated. This was done despite Datavault’s own Bylaws, which give only the full Board the power to remove officers.

The lawsuit further alleges that Moyer and certain unnamed directors shut Bradley out one day after he brought the company a $90–$100 million funding offer that could have substantially improved its financial position. Rather than present the offer, Moyer “suppressed, withheld and concealed” it from the company’s independent directors.

Last night, Bradley released the following statement:

“While I remain confident in Datavault AI’s technology, product offerings, and patent-protected innovations, I strongly dispute the legal validity of the Board’s decision to remove me as President and Chief Executive Officer.

“During my tenure, we increased revenue by more than 1,300% in my first year, alongside record trading volumes, and built the foundation for continued growth. We assembled a portfolio of more than

100 patents and pending applications, including newly issued U.S. patents in data valuation, tokenization, and wireless audio. We launched the Information Data Exchange, NIL Vault, and American Political Exchange, and signed licensing and tokenization agreements that bring real-world assets, from carbon credits to gold, copper, and geothermal energy, onto our platforms. We also completed strategic acquisitions, including API Media Innovations, that expanded our reach into digital twins, sports, and live events. We broadened our strategic partnership network, including with IBM,

ServiceNow, and the Department of Energy, and recruited industry-leading talent to the Datavault cause.

“Innovators are often targeted, and I intend to protect my rights and the interests of the Company and its shareholders. I believe the Board’s action jeopardizes the Company’s ability to realize its full potential.”

Jacob Frenkel, Bradley’s lead counsel and a former SEC enforcement lawyer and federal prosecutor, said:

“The company’s groundbreaking and cutting-edge technologies are a function of Mr. Bradley’s brilliance and vision. As a corporate leader, Mr. Bradley has a long-standing commitment to best practices in corporate governance.”

Mr. Bradley puts his investors first. When you’re out building and innovating and those you think you can trust decide to stage a corporate coup, the only place for relief is in court. Mr. Bradley will continue to fight for the shareholders and against those who put their own interests ahead of the company’s stakeholders.”

Read the full complaint here.

About Nathaniel Bradley:

Nathaniel Bradley is an inventor and technology executive who holds more than 70 patents. He founded and invented AudioEye, founded Intellectual Property Network Inc., and served as CTO of Marathon Patent Group (now Marathon Digital Holdings). In 2021, he founded Data Vault Holdings, whose assets were acquired in December 2024 by WiSA Technologies, the company that became Datavault AI. As CEO, he led the company through partnerships with IBM, Dolby Laboratories, and NYIAX, as well as the acquisition of CompuSystems assets.

View original content:https://www.prnewswire.com/news-releases/datavault-ai-founder-nathaniel-bradley-sues-board-302932495.html

SOURCE Datavault AI Inc

Continue Reading

Technology

County of Sussex, New Jersey Notice of Data Privacy Incident

Published

on

By

NEWTON, N.J., Nov. 6, 2026 /PRNewswire/ — Sussex County Prosecutor’s Office (SCPO) experienced a data privacy event that involved personal information.

On or about August 10, 2026, SCPO received alerts of a disruption to its computer network. Upon this identification, it launched an immediate investigation and engaged outside cybersecurity specialists to assist. The investigation determined that someone accessed its network without authorization between July 15, 2026, and July 22, 2026, and that certain files containing personal information were accessed and may have been taken. That information includes people’s first and last name, Social Security number, and driver’s license or State-issued identification card number. The SCPO has reported the incident to state and federal law enforcement, the New Jersey Cybersecurity and Communications Integration Cell (NJCCIC), and the Office of Attorney General. For more information on this incident, people may contact the call center at (888) 269-1448, Monday through Friday, 9:00 a.m. to 9:00 p.m. EST for further assistance.

Lauren Stinger, Esq.
Lauren.stinger@kennedyslaw.com
Associate Counsel

View original content:https://www.prnewswire.com/news-releases/county-of-sussex-new-jersey-notice-of-data-privacy-incident-302932369.html

SOURCE Kennedys CMK LLP

Continue Reading

Technology

Light AI Announces Resignation of Director and Officer

Published

on

By

VANCOUVER, BC, Nov. 6, 2026 /CNW/ — Light AI Inc. (“Light AI” or the “Company”) (CBOE CA: ALGO (FSE: OHC) (OTCQB: OHCFF), announces that Peter Whitehead has resigned as a director and the Chief Innovation Officer of the Company to pursue other opportunities. The Company would like to thank Mr. Whitehead for his contributions to the Company.

About Light AI Inc. (CBOE CA: ALGO / FSE: OHC / OTCQB: OHCFF)

Light AI Inc. is a healthcare technology company focused on developing artificial intelligence-powered SaMD solutions designed to support rapid, accessible clinical assessment at the point of care. The Company’s core technology, Light AI QuickScan™, is a device-agnostic software platform that applies proprietary artificial intelligence and machine learning algorithms to medical images. The QuickScan™ platform is designed to operate across compatible imaging and computing hardware, providing flexibility for integration into a range of healthcare devices, clinical workflows and care settings without dependence on a single proprietary hardware platform.

ON BEHALF OF THE COMPANY

“John R. Luna”
Chief Executive Officer

For more information, please contact the Company at investors@light.ai or visit https://light.ai/.

Website: https://light.ai/
LinkedIn: LinkedIn/company/Light AI
X (Formerly Twitter): @lightaihealth

SOURCE Light AI Inc.

Continue Reading

Trending